Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Akcea Reports Financial Results and Highlights for First Quarter 2019
May 8, 2019 4:07 PM EDTAchieved First Quarter 2019 TEGSEDI® (inotersen) Global Net Product Revenues of $7 Million
 Novartis exercised its option to license AKCEA-APO(a)-LRx
Received marketing authorization for WAYLIVRA® (volanesorsen) in E.U.
Conference Call Webcast Wednesday, May 8, 4:30 p.m. ET... More
